4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001209191-21-033402
Chief Financial Officer bought 2,500 shares at $15.85 ($39,625)
From the SEC's structured data for this filing
Trades in this filing
Henderson Molly · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-17 | Purchase : show line 1 in the form | +2,500 | $15.85 | $39,625 | 2,500 | D |
| Open-market purchases · 2,500 sh · avg $15.85 · $39,625 | ||||||
Loading xslF345X03/doc4.xml…